MedRx Co., Ltd (TYO: 4586)
Japan
· Delayed Price · Currency is JPY 82.00
+2.00 (2.50%)
Dec 30, 2024, 3:30 PM JST
MedRx Revenue
MedRx had revenue of 24.00M JPY in the quarter ending September 30, 2024, with 4.35% growth. This brings the company's revenue in the last twelve months to 255.00M, up 222.78% year-over-year. In the year 2023, MedRx had annual revenue of 29.00M, down -50.85%.
Revenue (ttm)
255.00M
Revenue Growth
+222.78%
P/S Ratio
13.25
Revenue / Employee
11.59M
Employees
22
Market Cap
3.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 29.00M | -30.00M | -50.85% |
| Dec 31, 2022 | 59.00M | 51.00M | 637.50% |
| Dec 31, 2021 | 8.00M | -107.00M | -93.04% |
| Dec 31, 2020 | 115.00M | -54.00M | -31.95% |
| Dec 31, 2019 | 169.00M | 161.00M | 2,012.50% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Otsuka Holdings | 2,269.56B |
| Terumo | 986.67B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |